Your browser doesn't support javascript.
loading
Haploidentical hematopoietic stem cell transplantation may improve long-term survival for children with high-risk T-cell acute lymphoblastic leukemia in first complete remission.
Zhang, Yongzhan; Bai, Lu; Cheng, Yifei; Lu, Aidong; Wang, Yu; Wu, Jun; Zhang, Xiaohui; Zuo, Yingxi; Xu, Lanping; Jia, Yueping; Huang, Xiaojun; Zhang, Leping.
Afiliação
  • Zhang Y; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing 100044, China.
  • Bai L; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Cheng Y; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Lu A; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing 100044, China.
  • Wang Y; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Wu J; Department of Pediatrics, Peking University Shougang Hospital, Peking University, Beijing 100144, China.
  • Zhang X; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Zuo Y; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing 100044, China.
  • Xu L; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Jia Y; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing 100044, China.
  • Huang X; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.
  • Zhang L; Department of Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, 2019RU029, Beijing, China.
Chin Med J (Engl) ; 135(8): 940-949, 2022 Apr 20.
Article em En | MEDLINE | ID: mdl-35730372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article